Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Promise and challenge: the lens model as a biomarker for early diagnosis of Alzheimer's disease.

Tian T, Zhang B, Jia Y, Li Z.

Dis Markers. 2014;2014:826503. doi: 10.1155/2014/826503. Epub 2014 Feb 12. Review.

2.

Cytosolic beta-amyloid deposition and supranuclear cataracts in lenses from people with Alzheimer's disease.

Goldstein LE, Muffat JA, Cherny RA, Moir RD, Ericsson MH, Huang X, Mavros C, Coccia JA, Faget KY, Fitch KA, Masters CL, Tanzi RE, Chylack LT Jr, Bush AI.

Lancet. 2003 Apr 12;361(9365):1258-65.

PMID:
12699953
3.

Alzheimer's disease amyloid-beta links lens and brain pathology in Down syndrome.

Moncaster JA, Pineda R, Moir RD, Lu S, Burton MA, Ghosh JG, Ericsson M, Soscia SJ, Mocofanescu A, Folkerth RD, Robb RM, Kuszak JR, Clark JI, Tanzi RE, Hunter DG, Goldstein LE.

PLoS One. 2010 May 20;5(5):e10659. doi: 10.1371/journal.pone.0010659.

4.

Alzheimer's disease.

De-Paula VJ, Radanovic M, Diniz BS, Forlenza OV.

Subcell Biochem. 2012;65:329-52. doi: 10.1007/978-94-007-5416-4_14. Review.

PMID:
23225010
5.
6.

Serum β-amyloid peptide levels spike in the early stage of Alzheimer-like plaque pathology in an APP/PS1 double transgenic mouse model.

He J, Qiao JP, Zhu S, Xue M, Chen W, Wang X, Tempier A, Huang Q, Kong J, Li XM.

Curr Alzheimer Res. 2013 Nov;10(9):979-86.

PMID:
24117120
7.

Ocular biomarkers for early detection of Alzheimer's disease.

Frost S, Martins RN, Kanagasingam Y.

J Alzheimers Dis. 2010;22(1):1-16. doi: 10.3233/JAD-2010-100819. Review.

PMID:
20847434
8.

Can the lens model provide a biomarker for Alzheimer's disease?

Tian T, Zhang B, Jia Y, Li Z.

Brain Pathol. 2013 Nov;23(6):696. doi: 10.1111/bpa.12072. No abstract available.

PMID:
24118485
9.

Amyloid imaging as a surrogate marker in clinical trials in Alzheimer's disease.

Scheinin NM, Scheinin M, Rinne JO.

Q J Nucl Med Mol Imaging. 2011 Jun;55(3):265-79. Review.

PMID:
21532540
10.

Alzheimer's disease in the retina: imaging retinal aβ plaques for early diagnosis and therapy assessment.

Koronyo Y, Salumbides BC, Black KL, Koronyo-Hamaoui M.

Neurodegener Dis. 2012;10(1-4):285-93. doi: 10.1159/000335154. Epub 2012 Feb 10. Review.

PMID:
22343730
11.

Ocular biomarkers of Alzheimer's disease.

Heaton GR, Davis BM, Turner LA, Cordeiro MF.

Cent Nerv Syst Agents Med Chem. 2015;15(2):117-25. Review.

PMID:
25788142
12.

Aβ40 oligomers identified as a potential biomarker for the diagnosis of Alzheimer's disease.

Gao CM, Yam AY, Wang X, Magdangal E, Salisbury C, Peretz D, Zuckermann RN, Connolly MD, Hansson O, Minthon L, Zetterberg H, Blennow K, Fedynyshyn JP, Allauzen S.

PLoS One. 2010 Dec 30;5(12):e15725. doi: 10.1371/journal.pone.0015725.

13.

Intracellular amyloid-β accumulation in calcium-binding protein-deficient neurons leads to amyloid-β plaque formation in animal model of Alzheimer's disease.

Moon M, Hong HS, Nam DW, Baik SH, Song H, Kook SY, Kim YS, Lee J, Mook-Jung I.

J Alzheimers Dis. 2012;29(3):615-28. doi: 10.3233/JAD-2011-111778.

PMID:
22269161
14.

Novel aβ isoforms in Alzheimer's disease - their role in diagnosis and treatment.

Portelius E, Mattsson N, Andreasson U, Blennow K, Zetterberg H.

Curr Pharm Des. 2011;17(25):2594-602. Review.

PMID:
21728980
15.

The heterogeneous nature of Cu2+ interactions with Alzheimer's amyloid-β peptide.

Drew SC, Barnham KJ.

Acc Chem Res. 2011 Nov 15;44(11):1146-55. doi: 10.1021/ar200014u. Epub 2011 Jun 29.

PMID:
21714485
16.

Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study.

Villemagne VL, Burnham S, Bourgeat P, Brown B, Ellis KA, Salvado O, Szoeke C, Macaulay SL, Martins R, Maruff P, Ames D, Rowe CC, Masters CL; Australian Imaging Biomarkers and Lifestyle (AIBL) Research Group.

Lancet Neurol. 2013 Apr;12(4):357-67. doi: 10.1016/S1474-4422(13)70044-9. Epub 2013 Mar 8.

PMID:
23477989
17.

Amyloid-peptide vaccinations reduce {beta}-amyloid plaques but exacerbate vascular deposition and inflammation in the retina of Alzheimer's transgenic mice.

Liu B, Rasool S, Yang Z, Glabe CG, Schreiber SS, Ge J, Tan Z.

Am J Pathol. 2009 Nov;175(5):2099-110. doi: 10.2353/ajpath.2009.090159. Epub 2009 Oct 15. Erratum in: Am J Pathol. 2010 Apr;176(4):2055.

18.

Alzheimer’s disease, cerebrovascular disease, and the β-amyloid cascade.

Honjo K, Black SE, Verhoeff NP.

Can J Neurol Sci. 2012 Nov;39(6):712-28. Review.

PMID:
23227576
19.

ApoE: the link between Alzheimer's-related glucose hypometabolism and Aβ deposition?

Patil SP, Ballard R, Sanchez S, Osborn J, Santangelo D Jr.

Med Hypotheses. 2012 Apr;78(4):494-6. doi: 10.1016/j.mehy.2012.01.015. Epub 2012 Jan 28.

PMID:
22285195
20.

Detection of Amyloid-beta aggregates in body fluids: a suitable method for early diagnosis of Alzheimer's disease?

Funke SA, Birkmann E, Willbold D.

Curr Alzheimer Res. 2009 Jun;6(3):285-9. Review.

PMID:
19519310
Items per page

Supplemental Content

Write to the Help Desk